You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

EVENTS

Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs

read more 

CORPORATE

Kedrion Biopharma and Kamada Ltd Receive FDA Approval for KEDRAB®

The product is approved for post-exposure prophylaxis against rabies infection

read more 

EVENTS

Kedrion Biopharma attends XXVI ISTH Congress in Berlin, Germany

A crowded symposium dedicated to the SIPPET Study was held on July 9th

read more 
  1. CORPORATE - 26-11-2014

    Kedrion receives the “VedoGreen, Green Excellence in Innovation” Award

    The awards ceremony held in Milan on November 17, during Waiting for Expo 2015, Green Economy 2.0

    read more 
  2. CORPORATE - 12-11-2014

    Kedrion joins the programme “ELITE for Large Corporates”

    Launched by Borsa Italiana, ELITE is targeted to companies aiming at strengthening their global leadership

    read more 
  3. EVENTS - 06-11-2014

    Kedrion Participates in International Event on Primary Immunodeficiencies

    Biennial Meeting of the European Society for Immunodeficiencies (ESID) took place in late October in Prague

    read more 
  4. CORPORATE - 17-10-2014

    Kedrion announces more factual, long-term role in Africa

    The company’s efforts try to grant African patients better access to treatments

    read more 

Pages

For more information please contact: pressoffice@kedrion.com